I’m the first person whose life was saved by CRISPR base editing

Alyssa Tapley, a 13-year-old girl, defied the odds when standard leukaemia treatments failed, and she was given just weeks to live. She then became the first person to undergo and benefit from an experimental CRISPR base editing procedure, which has saved her life. This groundbreaking case highlights the potential of gene-editing technology to revolutionize cancer treatment and offers hope for future patients facing similar dire diagnoses. The implications of this success could pave the way for more innovative, precise genetic therapies.